1. Salubrinal Enhances Doxorubicin Sensitivity in Human Cholangiocarcinoma Cells Through Promoting DNA Damage
   Wenjing Yu et al, 2018, Cancer Biotherapy and Radiopharmaceuticals CrossRef
2. Identification of key genes and pathways associated with cholangiocarcinoma development based on weighted gene correlation network analysis.
   Jingwei Liu et al, 2019, PeerJ CrossRef
3. Etoposide-mediated interleukin-8 secretion from bone marrow stromal cells induces hematopoietic stem cell mobilization
   Ka-Won Kang et al, 2020, BMC Cancer CrossRef
4. Upregulation of miR‑132‑3p in cholangiocarcinoma tissues: A study based on RT‑qPCR, The Cancer Genome Atlas miRNA sequencing, Gene Expression Omnibus microarray data and bioinformatics analyses
   Hua‑Yu Wu et al, 2019, Mol Med Report CrossRef
5. Construction of a model to predict the prognosis of patients with cholangiocarcinoma using alternative splicing events
   Hua‑Yu Wu et al, 2019, Oncol Lett CrossRef
6. Dinaciclib, a cyclin-dependent kinase inhibitor, suppresses cholangiocarcinoma growth by targeting CDK2/5/9
   Hera Saqub et al, 2020, Sci Rep CrossRef
7. Investigation of the relationship between CMYC gene polymorphisms and glioma susceptibility in Chinese children
   Susu Lou et al, 2021, Cancer Investigation CrossRef
8. Baicalin Induced Apoptosis of Human Cholangiocarcinoma Cell through Activating AMPK/mTORC1/p70S6K Signaling Pathway
   M. Jia et al, 2022, Bull Exp Biol Med CrossRef
9. Gastric cancer-derived mesenchymal stem cells promote gastric cancer cell lines migration by modulating CD276 expression
   Qiuzhi Gao et al, 2022, Experimental Cell Research CrossRef
10. Novel Adiponectin Receptor Agonist Inhibits Cholangiocarcinoma via Adenosine Monophosphate-activated Protein Kinase
    Khac Cuong Bui et al, 2024, CMC CrossRef